Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sen-Yuan Hong, Qi-Dong Xia, Yuan-Yuan Yang, Cong Li, Jia-Qiao Zhang, Jin-Zhou Xu, Bao-Long Qin, Yang Xun & Shao-Gang Wang. (2023) The role of microbiome: a novel insight into urolithiasis. Critical Reviews in Microbiology 49:2, pages 177-196.
Read now
Read now
Articles from other publishers (22)
Aaron W. Miller, Kristina L. Penniston, Kate Fitzpatrick, José Agudelo, Gregory Tasian & Dirk Lange. (2022) Mechanisms of the intestinal and urinary microbiome in kidney stone disease. Nature Reviews Urology 19:12, pages 695-707.
Crossref
Crossref
Xin Li, Li Wang, Shaojun Ma, Shaohui Lin, Chunyan Wang & Haiya Wang. (2022) Combination of Oxalobacter Formigenes and Veillonella Parvula in Gastrointestinal Microbiota Related to Bile-Acid Metabolism as a Biomarker for Hypertensive Nephropathy. International Journal of Hypertension 2022, pages 1-14.
Crossref
Crossref
Kyle Spradling, Calyani Ganesan & Simon Conti. (2022) Medical Treatment and Prevention of Urinary Stone Disease. Urologic Clinics of North America 49:2, pages 335-344.
Crossref
Crossref
David Lubkowicz, Nicholas G Horvath, Michael J James, Pasquale Cantarella, Lauren Renaud, Christopher G Bergeron, Ron B Shmueli, Cami Anderson, Jian‐Rong Gao, Caroline B Kurtz, Mylene Perreault, Mark R Charbonneau, Vincent M Isabella & David L Hava. (2022)
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and
in silico
simulations of enteric hyperoxaluria
. Molecular Systems Biology 18:3.
Crossref
Crossref
Yu Liu, Xi Jin, Yucheng Ma, Zhongyu Jian, Zhitao Wei, Liyuan Xiang, Qun Sun, Shiqian Qi, Kunjie Wang & Hong Li. (2021) Short-Chain Fatty Acids Reduced Renal Calcium Oxalate Stones by Regulating the Expression of Intestinal Oxalate Transporter SLC26A6. mSystems 6:6.
Crossref
Crossref
Sophie Marre, Cyrielle Gasc, Camille Forest, Yacine Lebbaoui, Pascale Mosoni & Pierre Peyret. (2021) Revealing microbial species diversity using sequence capture by hybridization. Microbial Genomics 7:12.
Crossref
Crossref
A. N. Obukhova & O. V. Khaletskaya. (2021) The secondary hyperoxaluria in children: the therapeutic potential of prebiotics and probiotics. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 66:2, pages 35-40.
Crossref
Crossref
Thi Phuong Nam Bui & Willem M. de Vos. (2021) Next-generation therapeutic bacteria for treatment of obesity, diabetes, and other endocrine diseases. Best Practice & Research Clinical Endocrinology & Metabolism 35:3, pages 101504.
Crossref
Crossref
S Shah Utsav, V Subramaniam & S Tamhankar Ashwin. (2021) Microbiome studies in urology- where do we stand and where can we reach?. Indian Journal of Medical Microbiology 39:1, pages 98-103.
Crossref
Crossref
Kait F. Al, Brendan A. Daisley, Ryan M. Chanyi, Jennifer Bjazevic, Hassan Razvi, Gregor Reid & Jeremy P. Burton. (2020) Oxalate-Degrading Bacillus subtilis Mitigates Urolithiasis in a Drosophila melanogaster Model. mSphere 5:5.
Crossref
Crossref
David Hontz, Jayden Hensley, Kayla Hiryak, Jennifer Lee, Jared Luchetta, Maria Torsiello, Michael Venditto, Del Lucent, William Terzaghi, Donald Mencer, Ajay Bommareddy & Adam L. VanWert. (2020) A Copper(II) Macrocycle Complex for Sensing Biologically Relevant Organic Anions in a Competitive Fluorescence Assay: Oxalate Sensor or Urate Sensor?. ACS Omega 5:31, pages 19469-19477.
Crossref
Crossref
Renato Nardi Pedro, Asad Ullah Aslam, Jibril Oyekunle Bello, Kamran Hassan Bhatti, Joseph Philipraj, Idrissa Sissoko, Giovanna Souza Vasconcellos, Alberto Trinchieri & Noor Buchholz. (2020) Nutrients, vitamins, probiotics and herbal products: an update of their role in urolithogenesis. Urolithiasis 48:4, pages 285-301.
Crossref
Crossref
Iryna Akulenko, Marharyta Skovorodka, Tetiana Serhiichuk & Ganna Tolstanova. (2020) The oxalate-degrading activity of Lactobacillus spp. isolated from different sources as the potential probiotic modulators for oxalate homeostasis. Journal of Microbiology & Experimentation 8:3, pages 118-123.
Crossref
Crossref
Liam Brennan, Kaitlin F. Al, Jennifer Bjazevic, Hassan Razvi & Jeremy P. Burton. 2019. The Role of Bacteria in Urology. The Role of Bacteria in Urology
79
93
.
Aaron W. Miller. 2019. The Role of Bacteria in Urology. The Role of Bacteria in Urology
179
186
.
Carlos A. BatagelloManoj MongaAaron W. Miller. (2018) Calcium Oxalate Urolithiasis: A Case of Missing Microbes?. Journal of Endourology 32:11, pages 995-1005.
Crossref
Crossref
Chenming Zhao, Huan Yang, Xiaojing Zhu, Yang Li, Ning Wang, Shanfu Han, Hua Xu, Zhiqiang Chen & Zhangqun Ye. (2018) Oxalate-Degrading Enzyme Recombined Lactic Acid Bacteria Strains Reduce Hyperoxaluria. Urology 113, pages 253.e1-253.e7.
Crossref
Crossref
Onur Kaygısız. 2017. Updates and Advances in Nephrolithiasis - Pathophysiology, Genetics, and Treatment Modalities. Updates and Advances in Nephrolithiasis - Pathophysiology, Genetics, and Treatment Modalities.
Shrikant S. Bhute, Saroj S. Ghaskadbi & Yogesh S. Shouche. 2017. Mining of Microbial Wealth and MetaGenomics. Mining of Microbial Wealth and MetaGenomics
133
142
.
Said Abdallah Al-MamariSaid Abdallah Al-Mamari. 2017. Urolithiasis in Clinical Practice. Urolithiasis in Clinical Practice
177
279
.
Ammon B. Peck, Benjamin K. Canales & Cuong Q. Nguyen. (2015) Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?. Urolithiasis 44:1, pages 45-50.
Crossref
Crossref
Jørgen Valeur. (2015) Probiotika mot nyrestein?. Tidsskrift for Den norske legeforening 135:11, pages 1035-1035.
Crossref
Crossref